Heart Metabolics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

Heart Metabolics General Information

Description

Developer of at-home cardiometabolic diagnostic testing designed to identify metabolic factors that contribute to cardiovascular risk and support informed heart health decisions. The company offers physician-reviewed testing panels covering advanced lipid markers, blood sugar, inflammation, insulin, metabolic, blood count, and thyroid measures, enabling consumers to better understand their cardiometabolic risk and take a more informed approach to long-term heart health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 701 East 60th Street North
  • Sioux Falls, SD 57104
  • United States
+1 (888)
Primary Industry
Diagnostic Equipment
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 701 East 60th Street North
  • Sioux Falls, SD 57104
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Heart Metabolics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Jan-2026 Completed Generating Revenue
3. Later Stage VC 01-Jan-2015 Completed Generating Revenue
2. Later Stage VC (Series A) 17-Apr-2014 $20M $24M Completed Generating Revenue
1. Later Stage VC (Series A) 04-Jan-2013 $4M $4M Completed Generating Revenue
To view Heart Metabolics’s complete valuation and funding history, request access »

Heart Metabolics Patents

Heart Metabolics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017153850-A1 Perhexiline dosing regimens for use in the treatment of hypertrophic cardiomyopathy Inactive 07-Mar-2016
JP-2015147787-A Treatment of heart failure with normal ejection fraction Pending 01-Apr-2015
WO-2015131231-A1 Methods for using (-)-perhexiline Inactive 03-Mar-2014
JP-2012527438-A Normal ejection fraction treatment for heart failure Pending 20-May-2009
AU-2009346606-A1 Treatment of heart failure with normal ejection fraction Active 20-May-2009 A61K31/4458
To view Heart Metabolics’s complete patent history, request access »

Heart Metabolics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Heart Metabolics FAQs

  • When was Heart Metabolics founded?

    Heart Metabolics was founded in 2004.

  • Where is Heart Metabolics headquartered?

    Heart Metabolics is headquartered in Sioux Falls, SD.

  • What is the size of Heart Metabolics?

    Heart Metabolics has 5 total employees.

  • What industry is Heart Metabolics in?

    Heart Metabolics’s primary industry is Diagnostic Equipment.

  • Is Heart Metabolics a private or public company?

    Heart Metabolics is a Private company.

  • What is Heart Metabolics’s current revenue?

    The current revenue for Heart Metabolics is .

  • How much funding has Heart Metabolics raised over time?

    Heart Metabolics has raised $40.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process